Division of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Chang Gung University College of Medicine, Kaohsiung, Taiwan.
PLoS One. 2022 Oct 7;17(10):e0275723. doi: 10.1371/journal.pone.0275723. eCollection 2022.
Endoscopic submucosal dissection (ESD) as an advanced endoscopic procedure can be considered for the removal of colorectal lesions with high suspicion of limited submucosal invasion or cannot be optimally removed by snare-based techniques. We aimed to analyze the clinical outcomes of ESD for colorectal neoplasms in our hospital.
We retrospectively enrolled 230 patients with 244 colorectal neoplasms who received ESD procedures from April 2012 to October 2020 at Kaohsiung Chang Gung Memorial Hospital. Clinicopathological data were collected by chart review. We also recorded ESD-related complications and clinical outcomes.
The average age was 64 years old, with a mean follow-up time of 22.59 months. There was a loss of follow-up in 34 lesions. Most lesions were lateral spreading tumors of the non-granular type. The average ESD time was 51.9 minutes. Nine cases (3.7%) had procedure-related complications, including two intra-procedure perforations (0.8%) and seven delayed bleeding (2.9%) without procedure-related mortality. 241 lesions (98.8%) achieved en-bloc resection, while 207 lesions (84.8%) achieved R0 resection. Most lesions were tubulo-(villous) adenoma. Malignancy included 35 adenocarcinomas and 5 neuroendocrine tumors. No local recurrence was developed during follow-up. Multivariate analysis for long ESD time revealed significance in size ≥ 10 cm2 and endoscopist's experience < 3 years. Pre-ESD endoscopic ultrasound revealed good prediction in discrimination of mucosal (sensitivity: 0.90) and submucosal lesion (specificity: 0.67).
ESD for colorectal neoplasms is an effective and safe technique. Size ≥ 10 cm2 and endoscopist's experience < 3 years were significantly associated with long procedure time. Pre-ESD EUS provided a good prediction for colorectal neoplasms in invasion depth.
内镜黏膜下剥离术(ESD)作为一种先进的内镜技术,可用于切除高度怀疑黏膜下浅层浸润或圈套技术无法完全切除的结直肠病变。本研究旨在分析本中心行 ESD 治疗结直肠肿瘤的临床疗效。
回顾性分析 2012 年 4 月至 2020 年 10 月在高雄长庚纪念医院接受 ESD 治疗的 230 例 244 枚结直肠肿瘤患者的临床资料。通过病历查阅收集患者的临床病理资料。同时记录 ESD 相关并发症及临床转归。
患者平均年龄 64 岁,平均随访时间为 22.59 个月,34 枚肿瘤失访。病变多为侧向发育型非颗粒状肿瘤。ESD 时间平均为 51.9 分钟。9 例(3.7%)出现与操作相关的并发症,其中 2 例术中穿孔(0.8%),7 例迟发性出血(2.9%),无与操作相关的死亡病例。241 枚(98.8%)肿瘤整块切除,207 枚(84.8%)达到 R0 切除。肿瘤多为管状(绒毛状)腺瘤,其中恶性肿瘤包括 35 例腺癌和 5 例神经内分泌肿瘤。随访期间无局部复发。多因素分析显示,肿瘤直径≥10cm2 和术者经验<3 年与 ESD 时间延长显著相关。ESD 术前超声内镜对区分黏膜层和黏膜下层病变具有良好的预测价值(黏膜层:敏感性 0.90;特异性 0.67)。
ESD 治疗结直肠肿瘤是一种有效、安全的技术。肿瘤直径≥10cm2 和术者经验<3 年与 ESD 时间延长显著相关。ESD 术前超声内镜有助于预测肿瘤的浸润深度。